Comment on FR Doc # 2026-09877, NRC-2025-1205-0001, from SOFIE
SOFIESupportBusiness
Summary: SOFIE Biosciences, a national PET radiopharmacy network, supports the NRC's proposed modernization of byproduct material regulations. They argue that the new rules will improve operational resilience, promote consistency across jurisdictions, and better align regulatory requirements with modern radiopharmaceutical technologies to improve patient access.
Please find attached SOFIE Biosciences' comments regarding Docket NRC-2025-1205, Modernizing NRC Regulations for Byproduct Material Use. Thank you.